Español 
Deutsch 
Français 
MSCI World Index (MSC)
NASDAQ Composite (NASDAQ)
FTSE China A50 Index (FGI)
STOXX Europe 600 (SIX)
Nikkei 300 (OSA)
NIFTY 50 (NSE)
DAX Performance Index (XETRA)
FTSE 100 (FGI)
CAC 40 (EURONEXT)
Chemplast Sanmar Limited (CHEMPLASTS.NS)
Chennai, IN
Chemplast Sanmar Limited is an Indian enterprise primarily involved in the creation and distribution of specialized chemical products. Their extensive range of offerings includes unique paste-grade PVC resins, alongside a variety of custom-made chemicals such as organic compounds and phytochemicals (like colchicine and thiocolchicoside). The company also produces chlorochemicals, which encompass items like caustic soda, various solvents, and refrigerant gases, in addition to industrial salt and hydrogen peroxide. These specialty PVC resins and bespoke chemicals primarily serve the needs of the agrochemical, pharmaceutical, and fine chemical sectors. Founded in 1967, the company is headquartered in Chennai, India. It was initially known as Chemicals and Plastics India Limited before rebranding to Chemplast Sanmar Limited in September 1995. The organization functions as a subsidiary of Sanmar Holdings Limited.
No mergers or acquisitions recorded for this company.
| Indicator | 1D | 1W | 2W | 3W | 1M |
|---|
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| -5.39% | +0.98% | -2.27% | -9.69% | -20.85% | -11.66% | -47.57% | -47.86% | -56.92% | -56.92% | -56.92% |
Revenue flow
Revenue by geography
Revenue by segment
Revenue composition
By product
By geography
Income Statement
Balance Sheet
Cash Flow Statement
Key Metrics
Financial Ratios
Employees
Financial Growth (CAGR)
Market Data
DCF figures are point estimates: small changes in growth or discount-rate assumptions move them materially. Read them as a reference, not a precise target.
| Rating | 2026-05 | Change |
|---|---|---|
| Strong Buy | 0 | 0 |
| Buy | 4 | 0 |
| Hold | 0 | 0 |
| Sell | 0 | 0 |
| Strong Sell | 0 | 0 |
-
Revenue growth Chemicals: +4.0%-2.8% Q1'26: +9.1% (vs Q1'25)
-
EPS growth Chemicals: +11.7%+58.5% ★ Q1'26: -422.1% (vs Q1'25)
-
FCF margin FCF growth · Chemicals: +41.7%-2.2% Q1'26: +0.0% (vs Q1'25)
-
EBIT margin Chemicals: +7.1%-1.2% Q1'26: +8.3% (vs Q1'25)
-
ROIC Chemicals: +3.4%-1.6% Q1'26: +9.7% (vs Q1'25)
-
Share dilution Chemicals: +0.0%+511.5% Q1'26: -84.0% (vs Q1'25)
-
Debt / EBITDA Net debt/EBITDA · Chemicals: 0.55×12.07× Q1'26: 3.08× (vs Q1'25)
* These projections are based on analyst consensus estimates and user-defined valuation multiples. This table is for informational purposes only and does not constitute a recommendation to buy or sell any security. Past performance is not indicative of future results.
| Metric |
Mar 2022 actual |
Mar 2023 actual |
Mar 2024 actual |
Mar 2025 actual |
Mar 2026 4 Rev. Ana. 4 EPS Ana. |
Mar 2027 4 Rev. Ana. 2 EPS Ana. |
Mar 2028 4 Rev. Ana. 4 EPS Ana. |
|---|---|---|---|---|---|---|---|
| Revenue |
58.85B
est: 58.92B (-0.1%)
|
49.41B
est: 49.41B (+0.0%)
|
39.16B
est: 40.71B (-3.8%)
|
43.46B
est: 43.71B (-0.6%)
|
41.00B
37.11B – 45.44B
-6.2% YoY
|
49.96B
46.83B – 52.08B
+21.9% YoY
|
57.08B
55.65B – 58.50B
+14.3% YoY
|
| EBITDA |
12.54B
est: 9.03B (+38.9%)
|
4.68B
est: 7.57B (-38.3%)
|
1.06B
est: 6.24B (-83.0%)
|
2.19B
est: 6.70B (-67.4%)
|
6.28B
5.69B – 6.96B
-6.2% YoY
|
7.66B
7.18B – 7.98B
+21.9% YoY
|
8.75B
8.53B – 8.96B
+14.3% YoY
|
| EBIT |
11.17B
est: 7.01B (+59.3%)
|
3.26B
est: 5.88B (-44.7%)
|
-450.50M
est: 4.85B (-109.3%)
|
197.60M
est: 5.20B (-96.2%)
|
4.88B
4.42B – 5.41B
-6.2% YoY
|
5.95B
5.57B – 6.20B
+21.9% YoY
|
6.79B
6.62B – 6.96B
+14.3% YoY
|
| Net Income |
6.49B
est: 6.66B (-2.6%)
|
1.52B
est: 2.11B (-27.8%)
|
-1.58B
est: -4.32B (+63.4%)
|
-1.10B
est: -4.49B (+75.4%)
|
-22.71B
-30.36B – -15.05B
-405.7% YoY
|
8.00B
6.49B – 9.50B
+135.2% YoY
|
24.10B
13.64B – 34.56B
+201.4% YoY
|
| SGA |
874.77M
est: 1.41B (-37.8%)
|
1.16B
est: 1.18B (-1.9%)
|
1.76B
est: 971.16M (+80.8%)
|
852.30M
est: 1.04B (-18.3%)
|
977.95M
885.28M – 1.08B
-6.2% YoY
|
1.19B
1.12B – 1.24B
+21.9% YoY
|
1.36B
1.33B – 1.40B
+14.3% YoY
|
| EPS |
43.66
est: 41.77 (+4.5%)
|
9.64
est: 13.23 (-27.1%)
|
-10.02
est: -4.46 (-124.6%)
|
-6.92
est: -4.63 (-49.4%)
|
-24.00
-31.14 – -15.44
-418.0% YoY
|
8.20
6.66 – 9.74
+134.2% YoY
|
23.40
13.98 – 35.44
+185.4% YoY
|
| Date | Rating | Overall | DCF | ROE | ROA | D/E | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
| 2026-05-26 | C+ | 2/5 | 3/5 | 1/5 | 1/5 | 1/5 | 1/5 | 5/5 |
| 2026-05-25 | C- | 1/5 | 3/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-22 | C- | 1/5 | 3/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-21 | C- | 1/5 | 3/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-20 | C- | 1/5 | 3/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-19 | C- | 1/5 | 4/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-18 | C- | 1/5 | 4/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-15 | C- | 1/5 | 4/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-14 | C- | 1/5 | 4/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-13 | C- | 1/5 | 4/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-12 | C- | 1/5 | 4/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-11 | C- | 1/5 | 4/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-08 | C- | 1/5 | 4/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-07 | C- | 1/5 | 4/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-06 | C- | 1/5 | 4/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-05 | C- | 1/5 | 4/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-04 | C- | 1/5 | 4/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-30 | C- | 1/5 | 4/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-29 | C- | 1/5 | 4/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-28 | C- | 1/5 | 4/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-27 | C- | 1/5 | 4/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-24 | C- | 1/5 | 4/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-23 | C- | 1/5 | 4/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-22 | C- | 1/5 | 4/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-21 | C- | 1/5 | 4/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-20 | C- | 1/5 | 4/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-17 | C- | 1/5 | 4/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-16 | C- | 1/5 | 4/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
Owner Earnings
Ownership Overview
Ownership breakdown not available.
No beneficial ownership filings recorded.
Institutional Activity (13F)
Institutional history not available.
Top holders not available.
ETF Ownership
| # | ETF | Weight | Est. AUM exposure | TER |
|---|---|---|---|---|
| 1 | Vanguard FTSE All-World ex-US Small-Cap ETF VSS | 0.00% | 526.2K | 0.06% |
| 2 | Vanguard FTSE Emerging Markets All Cap Index ETF VEE.TO | 0.00% | 44.1K | 0.26% |
| 3 | Vanguard FTSE Emerging Markets Shares ETF VGE.AX | 0.00% | 19.5K | 0.48% |
| 4 | Vanguard FTSE Emerging Markets ETF VWO | 0.00% | 2.18M | 0.06% |
| 5 | Vanguard ESG International Stock ETF VSGX | 0.00% | 25.2K | 0.10% |
| 6 | Vanguard Total International Stock ETF VXUS | 0.00% | 2.17M | 0.05% |
| 7 | Vanguard Total World Stock ETF VT | 0.00% | 203.5K | 0.06% |
| 8 | Vanguard FTSE Global All Cap ex Canada Index ETF VXC.TO | 0.00% | 3.5K | 0.22% |
| 9 | Vanguard All-Equity ETF Portfolio VEQT.TO | 0.00% | 10.5K | 0.22% |
| 10 | Vanguard Growth ETF Portfolio VGRO.TO | 0.00% | 5.7K | 0.22% |
Insider Activity
No insider activity available.
Insider history not available.
No recent insider transactions.
Executive team
Executive compensation
Executive compensation not available.
No CEO compensation history available.
Proxy statements
No proxy statements available for this company yet.
Recent SEC filings
No SEC filings available for this company yet.
Executive team
| Name | Title | Compensation | Gender |
|---|---|---|---|
| Ramkumar Shankar | MD & Director | 46M | male |
| Ganeshkumar | MD & Director | 46M | male |
| Krishnamoorthy | Executive Director of Commercial | — | male |
| Mahadevan Raman | Compliance Officer & Company Secretary | — | male |
| Mohith Balakrishnan | Senior General Manager of Human Resources | — | male |
| Natarajan Muralidharan | Chief Financial Officer | — | male |
| Palanisamy | Senior Vice President Operations of CCVL | — | male |
| S. Gajendiran | Executive Vice President of Operations & location Head of Mettur Facility | — | male |
| Sayi Subramaniyan | Senior Vice President of Strategic Sourcing | — | male |
| A. R. Balaji | Chief Financial Officer | — | male |
| Srinivasan | Compliance Officer & Company Secretary | — | male |
| Krishna Kumar Rangachari | Business Head of CMCD | — | — |
No data available for this company.
No Senate trading activity found for this company.
No House trading activity found for this company.
Share your view on this stock and instantly see how the community has voted over the last 6 months.
Community Opinion for CHEMPLASTS.NS
Short-term intention
Target Price Distribution
These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.
